B Group, Inc. Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$135.9B
Holdings
20
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (20 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ADMAADMA BIOLOGICS INC | 2,412,542 | $35.4B | 26.02% | |
| 2 | LLYELI LILLY & CO | 22,500 | $17.2B | 12.63% | Put |
| 3 | NVDANVIDIA CORPORATION | 75,000 | $14.0B | 10.29% | Put |
| 4 | ZLABZAI LAB LTD | 400,000 | $13.6B | 9.97% | |
| 5 | AKROAKERO THERAPEUTICS INC | 232,446 | $11.0B | 8.12% | |
| 6 | CLLSCELLECTIS S A | 3,281,501 | $9.4B | 6.88% | |
| 7 | TSHATAYSHA GENE THERAPIES INC | 1,800,556 | $5.9B | 4.33% | |
| 8 | ASMBASSEMBLY BIOSCIENCES INC | 175,706 | $4.5B | 3.31% | |
| 9 | NRXPWNRX PHARMACEUTICALS INC | 3,000,000 | $4.5B | 3.28% | |
| 10 | RAREULTRAGENYX PHARMACEUTICAL IN | 135,000 | $4.1B | 2.99% | |
| 11 | AURAAURA BIOSCIENCES INC | 572,576 | $3.5B | 2.60% | |
| 12 | IOVAIOVANCE BIOTHERAPEUTICS INC | 1,500,000 | $3.3B | 2.39% | |
| 13 | SGHTSIGHT SCIENCES INC | 930,000 | $3.2B | 2.35% | |
| 14 | SYRESPYRE THERAPEUTICS INC | 100,000 | $1.7B | 1.23% | |
| 15 | PRAXPRAXIS PRECISION MEDICINES I | 31,500 | $1.7B | 1.23% | |
| 16 | ORKAORUKA THERAPEUTICS INC | 75,000 | $1.4B | 1.06% | |
| 17 | APGEAPOGEE THERAPEUTICS INC | 35,000 | $1.4B | 1.02% | |
| 18 | REPLREPLIMUNE GROUP INC | 50,000 | $209.5M | 0.15% | Call |
| 19 | MJ0GAMESQUARE HLDGS INC | 250,000 | $169.7M | 0.12% | |
| 20 | IM8NINSMED INC | 158 | $22.8M | 0.02% |